Nuveen Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $2.89M | Sell |
201,061
-73
| -0% | -$1.05K | ﹤0.01% | 2231 |
|
|
2024
Q3 | $4.54M | Sell |
201,134
-66,544
| -25% | -$1.5M | ﹤0.01% | 2033 |
|
|
2024
Q2 | $5.21M | Buy |
267,678
+15,378
| +6% | +$299K | ﹤0.01% | 1935 |
|
|
2024
Q1 | $9.47M | Buy |
252,300
+697
| +0.3% | +$26.2K | ﹤0.01% | 1623 |
|
|
2023
Q4 | $14.1M | Buy |
251,603
+61,981
| +33% | +$3.47M | ﹤0.01% | 1375 |
|
|
2023
Q3 | $7.82M | Sell |
189,622
-65,016
| -26% | -$2.68M | ﹤0.01% | 1619 |
|
|
2023
Q2 | $14.2M | Sell |
254,638
-1,998
| -0.8% | -$112K | ﹤0.01% | 1297 |
|
|
2023
Q1 | $14.3M | Buy |
256,636
+37,298
| +17% | +$2.08M | 0.01% | 1255 |
|
|
2022
Q4 | $7.99M | Sell |
219,338
-5,533
| -2% | -$202K | ﹤0.01% | 1636 |
|
|
2022
Q3 | $6.4M | Sell |
224,871
-9,830
| -4% | -$280K | ﹤0.01% | 1751 |
|
|
2022
Q2 | $10.6M | Buy |
234,701
+30,784
| +15% | +$1.39M | ﹤0.01% | 1464 |
|
|
2022
Q1 | $13.6M | Buy |
203,917
+7,845
| +4% | +$522K | ﹤0.01% | 1449 |
|
|
2021
Q4 | $29.2M | Sell |
196,072
-10,058
| -5% | -$1.5M | 0.01% | 999 |
|
|
2021
Q3 | $30M | Sell |
206,130
-449,489
| -69% | -$65.4M | 0.01% | 994 |
|
|
2021
Q2 | $128M | Sell |
655,619
-394,107
| -38% | -$77.2M | 0.04% | 400 |
|
|
2021
Q1 | $190M | Sell |
1,049,726
-31,019
| -3% | -$5.61M | 0.06% | 288 |
|
|
2020
Q4 | $153M | Buy |
1,080,745
+79,339
| +8% | +$11.2M | 0.05% | 324 |
|
|
2020
Q3 | $125M | Buy |
1,001,406
+681,250
| +213% | +$84.9M | 0.05% | 311 |
|
|
2020
Q2 | $27.1M | Buy |
+320,156
| New | +$27.1M | 0.01% | 857 |
|